File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.hbpd.2019.08.001
- Scopus: eid_2-s2.0-85071511675
- PMID: 31474444
- WOS: WOS:000490834800007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Survival analysis of breast cancer liver metastasis treated by hepatectomy: a propensity score analysis for Chinese women in Hong Kong
Title | Survival analysis of breast cancer liver metastasis treated by hepatectomy: a propensity score analysis for Chinese women in Hong Kong |
---|---|
Authors | |
Keywords | Liver cancer Breast cancer Hepatectomy Metastases |
Issue Date | 2019 |
Publisher | Elsevier for the First Affiliated Hospital, Zhejiang University School of Medicine. The Journal's web site is located at http://www.hbpdint.com/ |
Citation | Hepatobiliary & Pancreatic Diseases International, 2019, v. 18 n. 5, p. 452-457 How to Cite? |
Abstract | Background:
Survival of patients with breast cancer liver metastasis is very poor. This study aimed to analyze the survival outcome of hepatectomy for this patient population.
Methods:
From January 1995 to December 2014, 2522 patients with liver cancer received hepatectomy at our hospital. Twenty-one of them, all female, received the operation for breast cancer liver metastasis. Performance was compared with patients with colorectal liver metastasis treated with hepatectomy after propensity score analysis in a ratio of 1:3.
Results:
Twenty-one patients received hepatectomy for breast cancer. After propensity score matching, 63 patients who had hepatectomy for colorectal cancer were selected for comparison. There was no significant difference in immediate or short-term outcomes between the two groups of patients in terms of operative time, blood loss and surgical morbidities. All patients with breast cancer had R0 resection. No hospital death occurred. After hepatectomy, the 1-, 3- and 5-year overall survival rates were 100.0%, 58.9% and 58.9% respectively in patients with breast cancer. The 1-, 3- and 5-year overall survival rates were 95.0%, 57.2% and 39.7% respectively in patients with colorectal cancer (P = 0.572). On multivariate analysis, triple negative status was the only independent poor prognostic factor in breast cancer liver metastasis (OR = 6.411; 95% CI: 1.351–30.435; P = 0.019).
Conclusions:
Hepatectomy is a safe and effective way of treating breast cancer liver metastasis at experienced centers where multidisciplinary adjuvant treatments are available. It can be considered more frequently as part of the multidisciplinary care for this patient population. |
Persistent Identifier | http://hdl.handle.net/10722/279186 |
ISSN | 2023 Impact Factor: 3.6 2023 SCImago Journal Rankings: 0.720 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, TT | - |
dc.contributor.author | Chok, KSH | - |
dc.contributor.author | Chan, ACY | - |
dc.contributor.author | Tsang, SHY | - |
dc.contributor.author | Dai, WC | - |
dc.contributor.author | Yau, TCC | - |
dc.contributor.author | Kwong, A | - |
dc.contributor.author | Lo, CM | - |
dc.date.accessioned | 2019-10-21T02:21:11Z | - |
dc.date.available | 2019-10-21T02:21:11Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Hepatobiliary & Pancreatic Diseases International, 2019, v. 18 n. 5, p. 452-457 | - |
dc.identifier.issn | 1499-3872 | - |
dc.identifier.uri | http://hdl.handle.net/10722/279186 | - |
dc.description.abstract | Background: Survival of patients with breast cancer liver metastasis is very poor. This study aimed to analyze the survival outcome of hepatectomy for this patient population. Methods: From January 1995 to December 2014, 2522 patients with liver cancer received hepatectomy at our hospital. Twenty-one of them, all female, received the operation for breast cancer liver metastasis. Performance was compared with patients with colorectal liver metastasis treated with hepatectomy after propensity score analysis in a ratio of 1:3. Results: Twenty-one patients received hepatectomy for breast cancer. After propensity score matching, 63 patients who had hepatectomy for colorectal cancer were selected for comparison. There was no significant difference in immediate or short-term outcomes between the two groups of patients in terms of operative time, blood loss and surgical morbidities. All patients with breast cancer had R0 resection. No hospital death occurred. After hepatectomy, the 1-, 3- and 5-year overall survival rates were 100.0%, 58.9% and 58.9% respectively in patients with breast cancer. The 1-, 3- and 5-year overall survival rates were 95.0%, 57.2% and 39.7% respectively in patients with colorectal cancer (P = 0.572). On multivariate analysis, triple negative status was the only independent poor prognostic factor in breast cancer liver metastasis (OR = 6.411; 95% CI: 1.351–30.435; P = 0.019). Conclusions: Hepatectomy is a safe and effective way of treating breast cancer liver metastasis at experienced centers where multidisciplinary adjuvant treatments are available. It can be considered more frequently as part of the multidisciplinary care for this patient population. | - |
dc.language | eng | - |
dc.publisher | Elsevier for the First Affiliated Hospital, Zhejiang University School of Medicine. The Journal's web site is located at http://www.hbpdint.com/ | - |
dc.relation.ispartof | Hepatobiliary & Pancreatic Diseases International | - |
dc.subject | Liver cancer | - |
dc.subject | Breast cancer | - |
dc.subject | Hepatectomy | - |
dc.subject | Metastases | - |
dc.title | Survival analysis of breast cancer liver metastasis treated by hepatectomy: a propensity score analysis for Chinese women in Hong Kong | - |
dc.type | Article | - |
dc.identifier.email | Cheung, TT: cheung68@hku.hk | - |
dc.identifier.email | Chok, KSH: chok6275@hku.hk | - |
dc.identifier.email | Chan, ACY: acchan@hku.hk | - |
dc.identifier.email | Dai, WC: daiwc@hku.hk | - |
dc.identifier.email | Yau, TCC: tyaucc@hku.hk | - |
dc.identifier.email | Kwong, A: avakwong@hku.hk | - |
dc.identifier.email | Lo, CM: chungmlo@hkucc.hku.hk | - |
dc.identifier.authority | Cheung, TT=rp02129 | - |
dc.identifier.authority | Chok, KSH=rp02110 | - |
dc.identifier.authority | Chan, ACY=rp00310 | - |
dc.identifier.authority | Yau, TCC=rp01466 | - |
dc.identifier.authority | Kwong, A=rp01734 | - |
dc.identifier.authority | Lo, CM=rp00412 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.hbpd.2019.08.001 | - |
dc.identifier.pmid | 31474444 | - |
dc.identifier.scopus | eid_2-s2.0-85071511675 | - |
dc.identifier.hkuros | 307915 | - |
dc.identifier.volume | 18 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 452 | - |
dc.identifier.epage | 457 | - |
dc.identifier.isi | WOS:000490834800007 | - |
dc.publisher.place | China | - |
dc.identifier.issnl | 2352-9377 | - |